The active, hormonal form of vitamin D-3 1,25-dihydroxyvitamin D, (1,25(OH)
,D,) has numerous pleiotropic actions including the regulation of calcium h
omeostasis, control of bone cell differentiation and modification of immune
responses. Synthesis of 1,25(OH)(2)D-3 from the major circulating metaboli
te, 25-hydroxyvitamin D-3 (25(OH)D-3), is catalysed by the mitochondrial cy
tochrome P450 enzyme 25-hydroxyvitamin D-1 alpha-hydroxylase (1 alpha-HYD).
Although 1 alpha-HYD activity has been demonstrated at several ectopic sit
es, circulating levels of 1,25(OH),D, appear to reflect the expression of t
his enzyme in the kidney. The tight regulation of 1 alpha-HYD in both renal
and ectopic tissues has made studies of the expression and regulation of t
his enzyme remarkably difficult. However, the recent cloning of mouse, rat
and human cDNAs for 1 alpha-HYD has stimulated renewed interest in the mole
cular endocrinology of 1,25(OH),D, production. Analysis of the 1 alpha-HYD
sequence has revealed homology with the liver enzyme vitamin D-25-hydroxyla
se, and the ubiquitously expressed vitamin D-24-hydroxylase. Furthermore, m
utations causing the inherited disorder vitamin D-dependent rickets type 1,
also known as pseudo-vitamin D deficiency rickets have been described for
the 1 alpha-HYD gene and these have been mapped to chromosome 12q14 by link
age analysis. The availability of sequence information for the 1 alpha-HYD
gene has also facilitated the development of new molecular tools which will
help to clarify key functions of the enzyme. Specific issues such as tissu
e distribution and regulatory pathways are discussed in this review, with p
articular emphasis on the role of 1 alpha-HYD in renal calcium/phosphate ho
meostasis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.